MGAT5 and cancer: In turn, the loss of GnT-V, ABO(H) terminal structures, sLea, Tn, galectin-8 and prostasin is associated with more aggressive cancer phenotypes, making them potential markers of poor prognosis [31, 32, 44-47, 50, 67, 105, 158-160, 200, 216].